Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: ENOV )

47.90 +1.23 (+2.62%)
Streaming Delayed Price Updated: 11:49 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ENOV

< Previous 1 2 Next >
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says
JMP Securities initiates coverage on Enovis Corporation with a Market Outperform rating, highlighting its strategic acquisitions, including LimaCorporate, and future growth potential. The analyst notes... 
Via Benzinga
The Latest Analyst Ratings For Enovis
Via Benzinga
ENOV Stock Earnings: Enovis Beats EPS, Misses Revenue for Q2 2024
ENOV stock results show that Enovis beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Critical Insights From Enovis Analyst Ratings: What You Need To Know
Via Benzinga
Top 3 Health Care Stocks That Could Blast Off In June
Via Benzinga
5 Medical Info Systems Stocks To Buy For Stable Returns
The medical info systems industry is thriving due to the growing demand for contactless services. Amid this environment, here are some stocks in the industry that may see stable returns in 2024. 
Via Talk Markets
A Closer Look at 6 Analyst Recommendations For Enovis
Via Benzinga
Earnings Outlook For Enovis
Via Benzinga
5 Analysts Have This To Say About Enovis
Via Benzinga
The Analyst Landscape: 6 Takes On Enovis
Via Benzinga
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
ENOV Stock Earnings: Enovis Beats EPS, Beats Revenue for Q1 2024
ENOV stock results show that Enovis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact
Enovis reports Q4 results with net sales surging 11% YoY, reaching $455 million. The growth is attributed to strong performance in P&R and above-market expansion in Recon, coupled with recent... 
Via Benzinga
Topics Earnings
Exposures Financial
This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis
William Bliar has initiated coverage on Enovis Corp (NYSE: ENOV), a medical technology company focusing on the orthopedics market valued at approximately $25 billion, experiencing steady growth,... 
Via Benzinga
This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch
Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising  
Via Benzinga
Analyst Ratings for Enovis
Via Benzinga
4 Analysts Have This to Say About Enovis
Via Benzinga
Looking Into Enovis's Return On Invested Capital
Via Benzinga
Enovis Beats Q1 Earnings Estimates, Raises 2023 Guidance
  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
Via Benzinga
Why Enovis Stock Is Trading Lower Today
Enovis Corporation (NYSE: ENOV) shares are trading lower on Thursday after the company announced a proposed private offering of $400 million of convertible senior notes and issued 
Via Benzinga
Big Moves In Orthopedics: Enovis Seals €800M Deal To Acquire LimaCorporate
Enovis Corp (NYSE: ENOV) inked a deal to acquire LimaCorporate S.p.A. for an 
Via Benzinga
Enovis Above-Market Growth Potential Surge Would Come from Market Share Gains and Accretive Acquisitions: Analyst
Needham initiated coverage on Enovis Corp (NYSE: ENOV) with a Buy and a price target of $70, noting that the company can sustain above-market growth in its Reconstructive segment via market share gains... 
Via Benzinga
Enovis: Q1 Earnings Insights
Via Benzinga
Earnings Outlook For Enovis
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
Via Benzinga
3 Dividend Stocks That Are Raising Their Payouts
Earnings have been remarkably resilient despite higher prices. Here are three dividend stocks that are increasing payouts as a result. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023
Via Benzinga
Hyatt Hotels To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Friday
Wells Fargo raised the price target for Enovis Corporation (NYSE: ENOV) from $55 to $67. Wells Fargo analyst Vik Chopra upgraded the stock from Equal-Weight to Overweight. Enovis shares rose 1.9% to... 
Via Benzinga
This Analyst With 83% Accuracy Rate Sees Around 11% Upside In Texas Roadhouse - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
U.S stocks closed higher on Friday, with the Dow Jones jumping more than 500 points during the session. 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.